Results 201 to 210 of about 30,063 (226)

Design, Synthesis and Evaluation of New GEQ Derivatives as Inhibitors of InhA Enzyme and Mycobacterium tuberculosis Growth

European Journal of Medicinal Chemistry, 2015
Christian Lherbet, Frédéric Rodriguez, Annaïk Quemard   +2 more
exaly  

New Direct Inhibitors of InhA With Antimycobacterial Activity Based on a Tetrahydropyran Scaffold

European Journal of Medicinal Chemistry, 2016
Izidor Sosič, Robert J Young, Stane Pajk   +2 more
exaly  

Synthesis and Biological Activities of Triazole Derivatives as Inhibitors of InhA and Antituberculosis Agents

European Journal of Medicinal Chemistry, 2011
Christian Lherbet, Frédéric Rodriguez, Michel Baltas   +2 more
exaly  

Inhibition of the Mycobacterium tuberculosis Enoyl Acyl Carrier Protein Reductase InhA by Arylamides

Bioorganic and Medicinal Chemistry, 2007
Akram Alian, Paul R Ortiz de Montellano
exaly  

DiscoveryofhydrazonecontainingthiadiazolesasMycobacteriumtuberculosisgrowth andenoylacylcarrierproteinreductase(InhA)inhibitors

2020
Gözde Gündüz, Miyase, Doğan, Hilal, Lherbet, Christian, Sriram, Dharmarajan, Şahin, Onur, Doğan, Dilem, Sarıpınar, Emin   +6 more
openaire   +1 more source

Discovery of Potential New InhA Direct Inhibitors Based on Pharmacophoreand 3D-QSAR Analysis Followed by in Silico Screening

European Journal of Medicinal Chemistry, 2009
Qidong You, Yong-Jun Jiang
exaly  

InhA, a Target of the Antituberculous Drug Isoniazid, Is Involved in a Mycobacterial Fatty Acid Elongation System, FAS-II

Microbiology (United Kingdom), 2000
Annaïk Quemard, Gilbert Lanéelle
exaly  

Pyrrolidinone and Pyrrolidine Derivatives: Evaluation as Inhibitors of InhA and Mycobacterium tuberculosis

European Journal of Medicinal Chemistry, 2016
Christian Lherbet, Frédéric Rodriguez, Zoia Voitenko   +2 more
exaly  

Development of 2-(4-Oxoquinazolin-3(4H)-Yl)Acetamide Derivatives as Novel Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors for the Treatment of Tuberculosis

European Journal of Medicinal Chemistry, 2014
Dharmarajan Sriram, Shalini Saxena, Parthiban Brindha Devi   +2 more
exaly  

Progress on the Discovery of Inhibitors of InhA, the FAS II Enoyl-ACP Reductase TB Drug Discovery Targeted on InhA

Letters in Drug Design & Discovery, 2016
Yi Zhang, Longxiang Xie, Jianping Xie
openaire   +1 more source